GlassScriptPhysician profile
Cheung K Leung
NPI 1427083112
$14,490.76
in general payments reported to CMS, 2019-2025
43 companies · $1,500 in 2025
The $1,500 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,597 · 2020: $1,462 · 2021: $2,562 · 2022: $2,676 · 2023: $1,714 · 2024: $1,979 · 2025: $1,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,193.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,992.50 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $1,397.39 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,027.74 | 2021-2024 | Verquvo, Lagevrio |
| Janssen Pharmaceuticals, INC | $855.62 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $616.41 | 2019-2022 | |
| Abbott Laboratories | $596.09 | 2019-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Bayer Healthcare Pharmaceuticals INC. | $571.80 | 2022-2024 | |
| Heartflow, INC. | $517.08 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $459.00 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $453.92 | 2019-2021 | |
| Esperion Therapeutics, INC. | $450.28 | 2020-2024 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $449.72 | 2020-2025 | Camzyos, Eliquis |
| Glaxosmithkline, LLC. | $359.51 | 2021-2023 | Arexvy |
| Alnylam Pharmaceuticals INC. | $336.04 | 2022 | |
| Boston Scientific Corporation | $314.96 | 2020-2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $293.30 | 2019-2023 | Jardiance |
| Medtronic Vascular, INC. | $279.38 | 2020 | |
| Edwards Lifesciences Corporation | $265.13 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Medtronic, INC. | $212.70 | 2021-2023 | Eea |
| Amgen INC. | $210.14 | 2019-2024 | Repatha |
| Vifor Pharma, INC. | $200.00 | 2021 | |
| Biotronik INC. | $198.40 | 2022-2025 | Amvia Edge |
| Kiniksa Pharmaceuticals International, Plc | $189.37 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $188.41 | 2019-2024 | Airsupra |
| Lilly USA, LLC | $146.89 | 2020-2022 | |
| Mylan Specialty L.P. | $107.79 | 2019-2022 | |
| Baxter Healthcare | $99.54 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $92.03 | 2019 | |
| Philips North America LLC | $91.50 | 2022-2025 | Vest Therapy Und, (8874) Incourage |
| Seqirus USA INC | $86.90 | 2022-2025 | Fluad, Flucelvax |
| Kowa Pharmaceuticals America, INC. | $60.85 | 2019-2020 | |
| Corcept Therapeutics | $59.35 | 2024 | Korlym |
| Irhythm Technologies, INC. | $51.99 | 2022 | |
| Artivion, INC. | $41.22 | 2022-2023 | Cryovalve Sg Pulmonary Human Heart Valve, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Avanir Pharmaceuticals, INC. | $33.47 | 2022 | |
| Abiomed | $33.30 | 2025 | |
| Abbvie INC. | $30.16 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $28.96 | 2023 | Arcalyst |
| Otsuka America Pharmaceutical, INC. | $27.31 | 2023 | Nuedexta |
| Atricure, INC. | $19.62 | 2024 | |
| Sanofi Pasteur INC. | $17.55 | 2022 | |
| Medicure Pharma INC. | $15.58 | 2021 | |
| Allergan, INC. | $11.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheung Leung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.